No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
78 |
4. Check minimum number of eventsNone |
78 |
5. Include endpointsNone |
78 |
6. Filter based on genotype QC (FinnGen only) |
78 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Syndactylia
Similar endpoints
↥List of similar endpoints to
Syndactyly
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1551 | 578 | 972 |
| Only index persons | 1116 | 439 | 677 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.03 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 2.12 | 3.83 | 1.06 |
| Only index persons | 4.99 | 9.40 | 2.12 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 78 | 51 | 27 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 21.64 | 16.34 | 31.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 70
- Matched controls
- 700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q70.9
ICD-10 Finland
Syndactyly, unspecified
+∞
35.4
31
*
Q70.1
ICD-10 Finland
Webbed fingers
+∞
16.3
15
*
Q70.0
ICD-10 Finland
Fused fingers
+∞
12.9
12
*
Q70.3
ICD-10 Finland
Webbed toes
+∞
11.8
11
*
NDT38
NOMESCO Finland
Correction of joined fingers
+∞
11.8
11
*
7551A
ICD-9 Finland
Other congenital anomalies of limbs, Syndactyly[SYNDACTYLIA]
+∞
8.5
8
*
9493
FHL
Reconstruction or shaping of hand skin and soft tissues, e.g. syndactyl
+∞
7.4
7
*
N07AA02
ATC
pyridostigmine; systemic
+∞
6.3
6
*
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
6.3
6
*
108
Kela drug reimbursment
Myasthenia gravis
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
23
111
2.52
3.13
3.9
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
71
2.78
3.06
2.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
31
175
2.28
2.97
6.5
5.4
inr
1.1
1.1
—
7
49
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
18
4.82
2.88
7.3
2.4
%
0.5
0.6
—
8
18
(3012544) pH of Venous blood
14
55
2.88
2.80
6.9
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
76
2.58
2.67
1.4
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
8
20
4.33
2.65
7.6
2.8
g/l
126.5
137.1
—
8
20
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
26
3.77
2.57
1.6
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
28
3.50
2.39
1.2
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
91
2.27
2.17
5.1
2.5
ng/l
305.3
298.0
0.01
12
50
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
10
5.26
2.10
1.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
12
4.37
1.85
1.4
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
55
2.40
1.78
1.3
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
27
172
1.87
1.75
3.1
2.9
e6/l
14.9
63.6
0.75
21
126
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
13
4.03
1.74
5.4
3.5
%
68.7
61.3
—
5
13
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
19
3.33
1.69
1.8
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
31
209
1.80
1.67
6.8
5.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
28
183
1.83
1.66
3.1
3.0
—
—
—
0
0
(4306422)
5
14
3.74
1.64
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
229
1.76
1.60
1.9
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
24
152
1.84
1.56
2.5
2.9
e6/l
0.2
0.2
0.04
15
109
(40768804) Tissue Pathology biopsy report
14
238
0.50
1.55
1.6
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
33
232
1.73
1.51
9.2
7.0
mmol/l
1.2
1.2
0.08
27
212
(3025941) Bacteria identified in Stool by Culture
10
46
2.35
1.47
1.8
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
29
203
1.68
1.32
3.8
3.5
e6/l
13.6
22.1
0.48
21
130
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
56
2.12
1.29
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
19
2.74
1.23
1.0
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
19
2.74
1.23
7.8
5.1
g/l
2.7
3.7
—
5
19
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
139
1.70
1.16
3.7
2.3
ng/l
17.9
51.5
—
10
66
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
31
2.38
1.13
1.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
41
2.06
1.12
1.9
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
12
67
1.93
1.12
1.7
2.3
g/l
2.7
2.5
0.78
12
61
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
13
75
1.88
1.11
1.7
1.6
pmol/l
861538811.1
457.2
0.78
13
66
(40768443) Skin Pathology biopsy report
5
21
2.47
1.10
1.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
22
2.36
1.05
79.8
10.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
26
187
1.59
1.04
11.0
4.8
g/l
36.3
37.5
0.48
26
181
(36304419) Bacteria [Presence] in Urine
22
152
1.62
1.03
2.5
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
13
78
1.80
0.99
11.5
3.6
mmol/l
0.8
0.8
0.31
13
73
(3022145) Colonoscopy Study observation
8
42
2.01
0.92
1.6
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
48
1.74
0.81
58.6
7.2
mmol/l
23.9
24.3
—
8
48
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.80
0.0
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
6
34
1.83
0.78
2.5
3.1
—
0.4
—
0
5
(3022948) Iron [Moles/volume] in Serum or Plasma
12
76
1.68
0.77
1.7
2.3
umol/l
16.3
15.7
0.07
12
68
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
110
1.57
0.76
4.5
2.3
mg/l
0.8
0.7
0.18
11
74
(3000991) Gas panel - Venous blood
9
56
1.69
0.75
49.3
8.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
149
1.46
0.66
5.7
7.3
—
—
—
0
0
(4010399)
5
30
1.71
0.62
1.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
20
151
1.44
0.62
2.7
2.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.8
—
1.2
—
0
20
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.8
—
0.2
—
0
20
(3009542) Hematocrit [Volume Fraction] of Blood
61
654
0.69
0.58
24.0
11.1
%
39.1
40.3
0.58
46
556
(3009508) Creatinine [Moles/volume] in Urine
11
156
0.66
0.57
2.5
2.6
mmol/l
7.4
8.6
0.43
11
137
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
26
209
1.37
0.57
3.5
2.7
u/l
32.5
31.6
0.05
26
201
(21494755) Public health laboratory ask at order entry panel
6
97
0.59
0.56
1.3
1.2
—
—
—
0
0
(3013512) EKG study
15
109
1.47
0.56
3.3
2.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
33
278
1.32
0.53
4.8
5.5
umol/l
9.4
10.4
0.35
33
258
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
93
1.48
0.52
2.4
2.9
e6/l
1.9
4.2
—
7
51
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
94
1.46
0.50
2.2
2.9
e6/l
1.8
0.8
—
6
53
(1761868) Lipid panel - Serum or Plasma
17
216
0.73
0.49
2.0
2.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
7
49
1.47
0.47
13.4
1.9
g/l
10.0
10.1
—
7
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
58
535
1.33
0.45
11.3
8.5
ml/min/173m2
93.5
96.8
0.52
46
410
(3044640) Blood type and Crossmatch panel - Blood
23
188
1.32
0.44
2.7
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
137
0.69
0.44
1.4
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
58
1.42
0.43
1.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
34
295
1.27
0.42
5.2
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
33
1.55
0.42
3.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
41
455
0.79
0.41
4.8
3.2
u/l
45.9
40.1
0.18
41
435
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
34
1.50
0.41
1.8
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
65
1.43
0.40
2.9
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
68
645
1.42
0.40
16.9
9.8
mg/l
29.7
21.7
0.81
52
470
(3002256) Pathology report gross observation
9
67
1.39
0.40
1.1
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
34
297
1.26
0.39
7.6
5.2
%
0.7
0.7
0.23
34
278
(3042936) Bacteria identified in Isolate by Culture
10
72
1.45
0.39
2.6
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
197
0.76
0.37
2.7
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
42
1.46
0.36
6.3
5.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
6
43
1.43
0.36
67.0
8.4
mmol/l
-0.4
1.1
—
6
37
(3035350) Ketones [Presence] in Urine by Test strip
33
290
1.24
0.35
3.5
2.9
estimate
0.0
0.0
—
6
56
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
6
44
1.39
0.35
1.7
3.4
pmol/l
4.7
4.9
—
6
39
(3028026) IgM [Mass/volume] in Serum or Plasma
6
44
1.39
0.35
1.7
1.5
g/l
1.2
1.1
—
6
39
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
63
595
1.31
0.35
4.5
4.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
45
1.36
0.34
2.0
2.3
—
21.1
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
51
547
0.80
0.34
3.0
2.9
mmol/l
1.1
1.2
0.24
51
513
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
16
129
1.30
0.33
2.9
2.2
u/l
87.1
219.9
1.50
16
129
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
118
0.73
0.30
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
180
1.23
0.27
1.9
1.7
pmol/l
104.9
96.1
0.36
15
96
(3015736) pH of Urine
27
239
1.20
0.26
3.5
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
32
289
1.18
0.24
5.1
4.3
estimate
0.0
0.0
—
6
55
(3019225) pH of Specimen
5
37
1.37
0.24
1.2
6.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
40
1.27
0.23
1.2
4.1
ug/l
1.9
12.0
—
5
30
(4094501)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
9.8
—
0.6
—
0
11
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
3.8
—
0.0
—
0
10
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
3.8
—
0.0
—
0
10
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
3.8
—
0.0
—
0
10
(3023420) DNA double strand Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
3.3
—
0.8
—
0
12
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.6
—
17.5
—
0
12
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
38
352
1.16
0.20
2.7
2.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
52
1.17
0.19
1.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
32
294
1.15
0.19
3.6
3.0
estimate
0.0
0.0
—
6
55
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
67
0.73
0.17
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
23
253
0.87
0.16
1.9
2.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
43
1.17
0.10
6.2
5.7
mmol/l
23.9
24.0
—
5
43
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
97
1.16
0.09
1.2
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
136
1.13
0.09
3.7
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
20
186
1.10
0.08
1.5
1.4
g/l
2.4
2.1
0.26
11
107
(40768797) Stomach Pathology biopsy report
7
68
1.03
0.08
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
74
0.80
0.08
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
83
1.10
0.07
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
100
0.89
0.07
1.9
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
26
247
1.08
0.06
1.7
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
10
110
0.90
0.05
1.7
1.3
nmol/l
27.6
19.6
—
10
91
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
140
1.09
0.05
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
15
140
1.09
0.05
4.1
3.1
estimate
0.0
0.0
—
6
55
(3041096) Erythrocytes [Presence] in Urine by Automated
18
171
1.07
0.03
3.1
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
213
1.05
0.01
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
176
0.96
0.00
2.8
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
186
0.96
0.00
1.5
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
122
0.98
0.00
1.8
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
43
429
1.01
0.00
3.9
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
217
1.02
0.00
4.1
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
145
1.04
0.00
4.5
3.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
119
1.01
0.00
2.0
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
144
0.97
0.00
3.2
2.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
14.7
—
1041.7
—
0
6
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
24.2
—
1982.7
—
0
6
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
4.0
—
29.2
—
0
6
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.4
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.5
—
0.9
—
0
6
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
44.8
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
32.3
—
0
8
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
89.1
—
0
5
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
50
1.00
0.00
3.0
3.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.9
—
51.5
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
78.1
—
0
7
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
59
0.84
0.00
3.2
3.4
%
32.0
33.1
—
5
40
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
10.4
—
0
7
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
6.4
—
0
7
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.8
—
48.6
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(40761511) CBC panel - Blood by Automated count
69
688
1.03
0.00
12.9
8.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.6
—
1.2
—
0
7
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_SYNDACTYLY and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_SYNDACTYLY.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_SYNDACTYLY – Syndactyly
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data